Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$42.05 - $47.77 $820,647 - $932,279
-19,516 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$40.23 - $47.74 $2.32 Million - $2.76 Million
-57,792 Reduced 74.76%
19,516 $853,000
Q4 2021

Feb 14, 2022

BUY
$38.88 - $45.31 $1.7 Million - $1.98 Million
43,728 Added 130.22%
77,308 $3.41 Million
Q3 2021

Nov 12, 2021

BUY
$38.79 - $43.16 $297,558 - $331,080
7,671 Added 29.61%
33,580 $1.29 Million
Q2 2021

Aug 06, 2021

BUY
$36.52 - $41.46 $494,079 - $560,912
13,529 Added 109.28%
25,909 $1.04 Million
Q1 2021

May 14, 2021

SELL
$34.27 - $40.01 $1.43 Million - $1.67 Million
-41,724 Reduced 77.12%
12,380 $450,000
Q4 2020

Feb 12, 2021

BUY
$34.07 - $39.94 $328,741 - $385,381
9,649 Added 21.71%
54,104 $2 Million
Q3 2020

Nov 13, 2020

BUY
$38.11 - $42.99 $300,840 - $339,363
7,894 Added 21.59%
44,455 $1.66 Million
Q2 2020

Aug 13, 2020

SELL
$37.87 - $43.58 $1.07 Million - $1.23 Million
-28,169 Reduced 43.52%
36,561 $1.49 Million
Q1 2020

May 11, 2020

BUY
$32.47 - $48.83 $1.39 Million - $2.09 Million
42,897 Added 196.48%
64,730 $2.43 Million
Q4 2019

Feb 12, 2020

SELL
$42.0 - $48.25 $1.09 Million - $1.25 Million
-25,872 Reduced 54.23%
21,833 $1.03 Million
Q2 2019

Aug 20, 2019

SELL
$39.4 - $42.7 $1.26 Million - $1.37 Million
-31,980 Reduced 40.13%
47,705 $1.91 Million
Q1 2019

May 15, 2019

BUY
$38.57 - $42.69 $1.56 Million - $1.73 Million
40,430 Added 102.99%
79,685 $3.33 Million
Q4 2018

Feb 14, 2019

SELL
$37.8 - $42.69 $506,897 - $572,472
-13,410 Reduced 25.46%
39,255 $1.5 Million
Q3 2018

Nov 14, 2018

BUY
$39.75 - $42.69 $1.45 Million - $1.56 Million
36,528 Added 226.36%
52,665 $2.12 Million
Q4 2017

Feb 14, 2018

BUY
$35.34 - $41.9 $328,591 - $389,586
9,298 Added 135.96%
16,137 $572,000
Q3 2017

Nov 15, 2017

BUY
$39.44 - $41.55 $269,730 - $284,160
6,839
6,839 $278,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.